A Repeated Time-to-Positive Symptoms Improvement among Malaysian Patients with Schizophrenia Spectrum Disorders Treated with Clozapine

Clozapine remains the drug of choice for resistant schizophrenia. However, its dose-response relationship is still controversial. The current investigation aimed to develop a repeated time-to-positive symptoms improvement following the onset of clozapine treatment in Malaysian schizophrenia spectrum...

Descripción completa

Detalles Bibliográficos
Autores principales: Albitar, Orwa, Harun, Sabariah Noor, Ahmad, Siti Nor Aizah, Sheikh Ghadzi, Siti Maisharah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401956/
https://www.ncbi.nlm.nih.gov/pubmed/34452082
http://dx.doi.org/10.3390/pharmaceutics13081121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401956/
https://www.ncbi.nlm.nih.gov/pubmed/34452082
http://dx.doi.org/10.3390/pharmaceutics13081121

Ejemplares similares